Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agricultural pesticide use and Alzheimer's disease dementia prevalence across US counties in a mixed supervised-unsupervised analysis.

Scientific reports·2026
Same author

Assessing the impact of neighborhood structures in Bayesian disease mapping.

Journal of applied statistics·2026
Same author

Bayesian multi-cell type models for the analysis of complex immune cell populations with application to ovarian cancer.

Briefings in bioinformatics·2026
Same author

Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma.

Clinical epigenetics·2025
Same author

Cigarette smoking in relation to survival in Black women with ovarian cancer: Evidence from the African American Cancer Epidemiology Study (AACES).

Annals of epidemiology·2025
Same author

Comparative evaluation of spatiotemporal methods for effective dengue cluster detection with a case study of national surveillance data in Thailand.

Scientific reports·2024

Related Experiment Video

Updated: May 16, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial.

Sheng Luo1, Andrew B Lawson2, Bo He3

  • 1Division of Biostatistics, The University of Texas Health Science Center at Houston, Houston, TX, USA sheng.t.luo@uth.tmc.edu.

Statistical Methods in Medical Research
|December 18, 2012
PubMed
Summary

This study introduces a new Bayesian imputation method for Parkinson's disease clinical trials. It accurately handles missing data in multiple outcomes, improving intent-to-treat analysis for longitudinal studies.

Keywords:
Clinical trialMarkov chain Monte Carloglobal statistical testitem-response theorylatent variablemissing data

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Related Experiment Videos

Last Updated: May 16, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Neurodegenerative Diseases

Background:

  • Parkinson's disease (PD) clinical trials frequently involve repeated measurements of diverse outcome types (binary, ordinal, continuous).
  • Missing data, due to reasons like dropout or death, are common and necessitate imputation for intent-to-treat (ITT) analyses.
  • Evaluating overall treatment effects requires robust methods that can handle missing data across multiple outcomes.

Purpose of the Study:

  • To propose and evaluate a novel Bayesian multiple imputation method for longitudinal studies with multiple outcomes.
  • To specifically address the challenges of missing data in Parkinson's disease clinical trials.
  • To compare the performance of the proposed method against standard imputation techniques.

Main Methods:

  • A Bayesian approach utilizing item response theory (IRT) for multiple imputation.
  • Accounting for multiple sources of correlation among outcomes.
  • Sensitivity analyses conducted under various missing data scenarios.

Main Results:

  • The proposed Bayesian IRT method demonstrated superior performance compared to traditional methods like Last Observation Carried Forward (LOCF) and separate random effects models.
  • Simulations confirmed the method's effectiveness in handling missing data in longitudinal settings.
  • The method was successfully applied to a real-world Parkinson's disease clinical trial.

Conclusions:

  • The developed Bayesian IRT method offers a powerful and accurate tool for imputing missing data in longitudinal studies with multiple outcomes.
  • This approach enhances the reliability of intent-to-treat analyses, particularly in complex clinical trial settings like Parkinson's disease research.
  • The method has broad applicability to various longitudinal studies facing challenges with missing data across multiple endpoints.